CDEK
← All drugs Report issue

chadox1

Vaccineexperimental

Clinical trial activity

46 trials · 82 clinical orgs · 0 marketing orgs

Phase 1
9
Phase 2
30
Phase 3
18
Phase 4
6

Earliest trial started Jun 1, 2012 (NCT01623518)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • chadox1

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06599658Phase 2Nov 20, 2024McGill University
NCT05909358Phase 1/Phase 2 (Phase 2)Jul 31, 2023Epicentre, Government of Uganda, Makerere University, Medical Research Council-UVRI Uganda Research Unit on AIDS
NCT05812586Phase 3Mar 14, 2023Bill and Melinda Gates Foundation, D'Or Institute for Research and Education, University of Oxford
NCT05710783Phase 2/Phase 3 (Phase 3)Nov 9, 2022Government of Mexico, Instituto Nacional de Enfermedades Respiratorias, Laboratorio Avi-Mex, S.A. de C.V.
NCT05572879Phase 3Oct 1, 2022EuBiologics Co.,Ltd
NCT05470803Phase 3Aug 31, 2022Bill and Melinda Gates Foundation, D'Or Institute for Research and Education, University of Oxford
NCT05465902Phase 2Jul 31, 2022Government of China
NCT05198596Phase 3Jul 30, 2022Medigen Biotechnology Corporation
NCT05603052Phase 3Jul 11, 2022EuBiologics Co.,Ltd
NCT05426343Phase 3Jul 9, 2022Medigen Biotechnology Corporation
NCT05343871Phase 4Jul 5, 2022Aga Khan University, Albert B. Sabin Vaccine Institute, Oswaldo Cruz Foundation, Stanford University
NCT05197153Phase 2Jan 22, 2022Coalition for Epidemic Preparedness Innovations, Medigen Biotechnology Corporation
NCT05162482Phase 2Jan 1, 2022Aga Khan University, Chughtai Lab, Coalition for Epidemic Preparedness Innovations, Government of Pakistan, Harvard University, International Vaccine Institute, University of Oxford
NCT05057897Phase 4Dec 22, 2021AstraZeneca
NCT05087368Phase 2Dec 1, 2021Bill and Melinda Gates Foundation, D'Or Institute for Research and Education, Instituto de Medicina Integral Professor Fernando Figueira, University of Oxford
NCT05011526Phase 3Oct 31, 2021Medigen Biotechnology Corporation, University of Asuncion
NCT05007275Phase 1Sep 30, 2021AstraZeneca, Imperial College London, University of Oxford
NCT05289206N/ASep 30, 2021Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Oswaldo Cruz Foundation, Universidade do Estado do Amazonas, XP Investimentos
NCT05049226Phase 2Sep 24, 2021Chiangmai University, Chulalongkorn University, Clinixir Co., Ltd., KhonKaen University, Mahidol University, Prince of Songkla University, Thammasat University
NCT04684446Phase 1/Phase 2 (Phase 2)Sep 15, 2021AstraZeneca, Government of Russia, R-Pharm, The Gamaleya National Center of Epidemiology & Microbiology
Showing 20 of 46 trials
Page 1 / 3

Organizations

Research & Development (82)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AstraZenecaFor profit11542020
University of OxfordAcademic/Hospital8332012
Coalition for Epidemic Preparedness InnovationsAcademic/Hospital4022021
Medigen Biotechnology CorporationFor profit4422021
Bill and Melinda Gates FoundationAcademic/Hospital3022021
D'Or Institute for Research and EducationAcademic/Hospital3322021
Government of RussiaGovernment3012021
Harvard UniversityAcademic/Hospital3012021
International Vaccine InstituteAcademic/Hospital3122021
IQVIAFor profit3022020
R-PharmFor profit3312021
Aga Khan UniversityAcademic/Hospital2122022
EuBiologics Co.,LtdFor profit2212022
Federal University of Espirito SantoAcademic/Hospital2222021
Federal University of Minas GeraisAcademic/Hospital2022021
Oswaldo Cruz FoundationAcademic/Hospital2022021
The Gamaleya National Center of Epidemiology & MicrobiologyAcademic/Hospital2012021
Ain Shams UniversityAcademic/Hospital1112021
Albert B. Sabin Vaccine InstituteAcademic/Hospital1112022
Arena PharmaceuticalsFor profit1112021
82 organizations
Page 1 / 5